Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Causes}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Causes}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ||
| Line 10: | Line 8: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular tachycardia | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular tachycardia | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| Line 18: | Line 14: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular fibrillation | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular fibrillation | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| Line 26: | Line 20: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Asystole | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Asystole | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| Line 34: | Line 26: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulseless electrical activity | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulseless electrical activity | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| Line 42: | Line 32: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulmonary embolism | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulmonary embolism | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Revision as of 18:50, 16 January 2020
| Disease Name | Causes | ECG Characteristics | ECG view | Prognosis |
|---|---|---|---|---|
| Ventricular tachycardia | ||||
| Ventricular fibrillation | ||||
| Asystole | ||||
| Pulseless electrical activity | ||||
| Pulmonary embolism |
| Disease Name | Age of Onset | Gender Preponderance | Signs/Symptoms | Imaging Feature(s) | Macroscopic Feature(s) | Microscopic Feature(s) | Laboratory Findings(s) | Other Feature(s) | ECG view |
|---|---|---|---|---|---|---|---|---|---|